Nijia Chang

Silenced LINC01134 Enhances Oxaliplatin Sensitivity by Facilitating Ferroptosis Through GPX4 in Hepatocarcinoma

Y. Huo, Qing Zhou, Rong-kuan Li, 2022, Frontiers in Oncology.

A nomogram-based immunoprofile predicts clinical outcomes for stage II and III human colorectal cancer

S. Jiao, Liangliang Wu, Jinfeng Li, 2021, Molecular and clinical oncology.

Patients with advanced non-small cell lung cancer with EGFR mutations in addition to complex mutations treated with osimertinib have a poor clinical outcome: A real-world data analysis

Zhe-feng Liu, Jingjing Duan, Lingxiong Wang, 2020, Oncology letters.

Corrigendum to "Lenvatinib plus sintilimab versus lenvatinib monotherapy as first-line treatment for advanced HBV-related hepatocellular carcinoma: A retrospective, real-world study" [Heliyon 8 (6) (2022) e09538].

Zhe Xu, Lei Zhao, Xiaohui Xie, 2022, Heliyon.